Weston Young, DO
Family Medicine · Phoenix, AZNPI 1538456470
Payments from drug & device makers
Across 111 payments — averaging $29.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1K
- AbbVie$225
- Amgen$216
- Eko Health, Inc.$200
- Novo Nordisk$199
- Lilly USA, LLC$169
- plus $940 from 23 others
What the payments were for
- Speaking & faculty fees$20010%
- Food & beverage$1,79690%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 5 | $1,304 |
| AbbVie(2 entities) | 13 | $225 |
| Amgen | 15 | $216 |
| Eko Health, Inc. | 1 | $200 |
| Novo Nordisk | 12 | $199 |
| Lilly USA, LLC | 11 | $169 |
| AstraZeneca | 10 | $141 |
| Boehringer Ingelheim | 7 | $115 |
| Abbott | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $78 |
| GSK | 4 | $67 |
| Topcon Healthcare Solutions, Inc. | 1 | $47 |
| Nalpropion Pharmaceuticals LLC | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Pfizer | 2 | $34 |
| Boston Scientific | 2 | $30 |
| Exact Sciences | 2 | $28 |
| Viatris Specialty LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Impulse Dynamics (USA) Inc. | 1 | $24 |
| Edwards Lifesciences | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Teleflex LLC | 1 | $18 |
| Kaleo, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Intra-sana Laboratories | 1 | $15 |
| Shire North American Group Inc | 1 | $13 |
How this compares
$3,252 in reported general payments places this provider in the 85th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 33 | $44,275 |
| JardianceEmpagliflozin | 20 | $25,854 |
| EliquisApixaban | 11 | $20,159 |
| Celecoxib | 13 | $1,985 |
| Rosuvastatin Calcium | 92 | $1,624 |
| Atorvastatin Calcium | 84 | $1,028 |
| Gabapentin | 61 | $866 |
| Tamsulosin Hcl | 43 | $785 |
| Omeprazole | 75 | $691 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $690 |
| Losartan Potassium | 83 | $674 |
| Levocetirizine Dihydrochloride | 14 | $598 |
| Metformin Hcl | 59 | $487 |
| ValacyclovirValacyclovir Hcl | 11 | $479 |
| Levothyroxine Sodium | 65 | $478 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $199 | $44,27533 claims |
| Boehringer IngelheimJardiance | $115 | $25,85420 claims |
| PfizerEliquis | $34 | $20,15911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Phoenix
- Brock MerrittPhoenix$8.4M
- Douglas CunninghamPhoenix$4.9M
- Jeffrey ZacherPhoenix$2M
- Trisha TavaresPhoenix$1.6M
- David FrancykPhoenix$1.3M
- James BeachPhoenix$1.2M
- Peter LevinsPhoenix$971K
- Elysa ShawPhoenix$774K
- Mitchell EdelsteinPhoenix$741K
- Brian DedinskyPhoenix$589K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.